• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    6/16/23 1:08:12 PM ET
    $ADBE
    $ADRT
    $APPH
    $ATIP
    Computer Software: Prepackaged Software
    Technology
    Blank Checks
    Finance
    Get the next $ADBE alert in real time by email

    Gainers

    • Oncorus, Inc. (NASDAQ:ONCR) shares surged 258% to $0.2781.
    • Evelo Biosciences, Inc. (NASDAQ:EVLO) shares jumped 216.2% to $0.2622 after the company won U.S. Patent for prebiotic compositions and methods of use thereof for modulation of the microbiome.
    • Navidea Biopharmaceuticals, Inc. (NASDAQ:NAVB) gained 58% to $0.1296. Navidea Biopharmaceutical recently posted a narrower first-quarter loss.
    • Virgin Galactic Holdings, Inc. (NYSE:SPCE) shares climbed 32.1% to $5.36 as the company announced the start of commercial spaceline operations. The company said its first commercial spaceflight, "Galactic 01," is set to fly between June 27 and June 30.
    • Plutonian Acquisition Corp. (NASDAQ:PLTNR) shares surged 24.2% to $0.41 after jumping 32% on Thursday.
    • Microbot Medical Inc. (NASDAQ:MBOT) rose 21.7% to $3.48. Microbot Medical announced multiple peer reviewed abstracts accepted by the Cardiovascular and Interventional Radiological Society of Europe.
    • VCI Global Limited (NASDAQ:VCIG) gained 20.2% to $2.91 after it announced a partnership with Fusionex to provide Artificial Intelligence and Big Data Services to clients.
    • iRobot Corporation (NASDAQ:IRBT) shares climbed 19.2% to $50.15 after UK's Competition and Markets Authority cleared its acquisition deal with Amazon.
    • NeuBase Therapeutics, Inc. (NASDAQ:NBSE) gained 17% to $3.2295. NeuBase Therapeutics recently announced a 1-for-20 reverse stock split.
    • Humanigen, Inc. (NASDAQ:HGEN) shares rose 16.2% to $0.1866. Humanigen recently presented promising new hematologic data from PREACH-M trial for chronic myelomonocytic leukemia treatment at the 2023 European Hematology Association Congress.
    • INVO Bioscience, Inc. (NASDAQ:INVO) gained 15.4% to $0.1960.
    • SmileDirectClub, Inc. (NASDAQ:SDC) climbed 15% to $0.4950.
    • AppHarvest, Inc. (NASDAQ:APPH) gained 14.1% to $0.4599.
    • OpGen, Inc. (NASDAQ:OPGN) shares climbed 13.9% to $0.6950. OpGen, last month, posted a wider-than-expected quarterly loss.
    • Ault Disruptive Technologies Corporation (NYSE:ADRT) shares gained 13.8% to $12.40.
    • Lordstown Motors Corp. (NASDAQ:RIDE) gained 13.3% to $4.7683..
    • Cohen & Company Inc. (NYSE:COHN) rose 13.3% to $5.11.
    • TMC the metals company Inc. (NASDAQ:TMC) surged 11.6% to $1.23.
    • Ontrak, Inc. (NASDAQ:OTRK) gained 10.8% to $0.6095.
    • FingerMotion, Inc. (NASDAQ:FNGR) shares gained 10.8% to $2.25 after climbing over 18% on Thursday.
    • Nikola Corporation (NASDAQ:NKLA) gained 8.6% to $1.52 after gaining around 30% on Thursday. The EV maker also gained last week after shareholders reportedly rejected the company's proposal to issue more stock shares.
    • Community Health Systems, Inc. (NYSE:CYH) rose 8.3% to $4.4185.
    • Eneti Inc. (NYSE:NETI) gained 8.2% to $12.68 after the company and Cadeler A/S announced they have entered into a business combination agreement to combine through a stock-for-stock exchange.
    • COMSovereign Holding Corp. (NASDAQ:COMS) gained 8.1% to $2.00.
    • Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) rose 7.5% to $0.1930. MEI Pharma and Infinity Pharmaceuticals, said that the companies will host a recorded joint video webcast that will be available at 8:00 am Eastern Time on June 19, 2023.
    • Squarespace, Inc. (NYSE:SQSP) shares rose 7.2% to $33.64 after the company announced it entered into a definitive agreement to acquire Google Domains assets.
    • NaaS Technology Inc. (NASDAQ:NAAS) gained 6.8% to $6.60 following quarterly results.
    • MorphoSys AG (NASDAQ:MOR) rose 6.5% to $7.57. JP Morgan upgraded MorphoSys from Underweight to Overweight and raised the price target from $3.3 to $10.
    • Adobe Inc. (NASDAQ:ADBE) shares gained 2.2% to $501.63 as the company reported better-than-expected results for its second quarter and issued strong earnings forecast.

    Losers

    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares fell 52.5% to $2.76 after the company announced pricing of an approximately $8.5 million public offering,
    • Applied UV, Inc. (NASDAQ:AUVI) fell 42.1% to $1.10. Applied UV retained Quantiva to integrate AI and machine learning capabilities into its PURONetaAnd Airocide Systems.
    • Universe Pharmaceuticals INC (NASDAQ:UPC) dropped 30.1% to $0.58.
    • EdtechX Holdings Acquisition Corp. II (NASDAQ:EDTX) shares dropped 20.5% to $26.89 after jumping 207% on Thursday. The company announced Wednesday an amendment to extend the date to consummate a business combination from June 15, 2023 to Dec. 15, 2023.
    • Clene Inc. (NASDAQ:CLNN) fell 19.1% to $0.85 after the company announced pricing of a $40 million public offering. Clene’s CNM-Au8 treatment demonstrated a statistically significant reduction of plasma neurofilament light chain levels compared to placebo at 24 weeks.
    • Coherus BioSciences, Inc. (NASDAQ:CHRS) fell 16.8% to $4.48. Coherus BioSciences agreed to acquire Surface Oncology Inc (NASDAQ:SURF), a clinical-stage immuno-oncology (I-O) company developing next-generation immunotherapies that target the tumor microenvironment.
    • Jeffs' Brands Ltd (NASDAQ:JFBR) dropped 16.5% to $0.9101.
    • Stereotaxis, Inc. (NYSE:STXS) fell 14.5% to $1.7275. Stereotaxis will initiate first-in-human trial to support CE Mark application of MAGiC Catheter.
    • Leju Holdings Limited (NYSE:LEJU) shares dropped 14.1% to $3.2897 after gaining 31% on Thursday.
    • AEye, Inc. (NASDAQ:LIDR) fell 13.6% to $0.1988.
    • ATI Physical Therapy, Inc. (NYSE:ATIP) dropped 13.5% to $8.83. ATI Physical Therapy completed transaction support agreement to increase liquidity and financial flexibility.
    • VIQ Solutions Inc. (NASDAQ:VQS) shares fell 13.5% to $0.3009. VIQ Solutions shares gained 32% on Thursday after the company partnered Justice AV Solutions to bring AI-generated draft transcripts of courtroom proceedings.
    • Healthcare Triangle, Inc. (NASDAQ:HCTI) dropped 13.4% to $2.83.
    • Cabot Corporation (NYSE:CBT) fell 10.4% to $66.83 after the company disclosed the impact of the current demand environment on its business segments.
    • Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) fell 10.1% to $5.10 after jumping around 25% on Thursday. The company recently reported a $2 million buyback program.
    • Axcella Health Inc. (NASDAQ:AXLA) dropped 9.9% to $0.2821.
    • MicroVision, Inc. (NASDAQ:MVIS) fell 9.4% to $4.5750. Microvision said it entered into sales agreement with Craig-Hallum Capital Group relating to sale of up to $45 million of company’s common stock.
    • Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) fell 8.2% to $8.34.
    • Tenon Medical, Inc. (NASDAQ:TNON) fell 7.9% to $0.3009 after adding 16% on Thursday. Tenon Medical recently priced its public offering of $5.6M at $0.56 per unit.
    • ZoomInfo Technologies Inc. (NASDAQ:ZI) dropped 7.5% to $26.27.

     

    Now Read This: Bitcoin Surpasses This Key Level; Trust Wallet Token Emerges As Top Gainer

    Get the next $ADBE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADBE
    $ADRT
    $APPH
    $ATIP

    CompanyDatePrice TargetRatingAnalyst
    Olema Pharmaceuticals Inc.
    $OLMA
    2/11/2026$48.00Buy
    Stifel
    Microbot Medical Inc.
    $MBOT
    2/10/2026$5.00Buy
    B. Riley Securities
    Cabot Corporation
    $CBT
    2/5/2026$75.00Outperform → Neutral
    Mizuho
    Adobe Inc.
    $ADBE
    2/3/2026$330.00Overweight → Neutral
    Piper Sandler
    Coherus Oncology Inc.
    $CHRS
    1/23/2026$10.00Outperform
    Oppenheimer
    Adobe Inc.
    $ADBE
    1/13/2026Outperform → Perform
    Oppenheimer
    Adobe Inc.
    $ADBE
    1/12/2026$290.00Sell
    Goldman
    Adobe Inc.
    $ADBE
    1/9/2026$375.00Outperform → Market Perform
    BMO Capital Markets
    More analyst ratings

    $ADBE
    $ADRT
    $APPH
    $ATIP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel initiated coverage on Olema Pharmaceuticals with a new price target

    Stifel initiated coverage of Olema Pharmaceuticals with a rating of Buy and set a new price target of $48.00

    2/11/26 7:52:37 AM ET
    $OLMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    B. Riley Securities initiated coverage on Microbot Medical with a new price target

    B. Riley Securities initiated coverage of Microbot Medical with a rating of Buy and set a new price target of $5.00

    2/10/26 8:01:31 AM ET
    $MBOT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Cabot downgraded by Mizuho with a new price target

    Mizuho downgraded Cabot from Outperform to Neutral and set a new price target of $75.00

    2/5/26 6:53:33 AM ET
    $CBT
    Major Chemicals
    Industrials

    $ADBE
    $ADRT
    $APPH
    $ATIP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Vaknin Rachel

    4 - Microbot Medical Inc. (0000883975) (Issuer)

    2/20/26 4:45:18 PM ET
    $MBOT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Chairman, President and CEO Gadot Harel

    4 - Microbot Medical Inc. (0000883975) (Issuer)

    2/20/26 4:45:22 PM ET
    $MBOT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by General Manager, CTO Sharon Simon

    4 - Microbot Medical Inc. (0000883975) (Issuer)

    2/20/26 4:45:19 PM ET
    $MBOT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADBE
    $ADRT
    $APPH
    $ATIP
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for CIMERLI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug CIMERLI (SUPPL-5) with active ingredient RANIBIZUMAB-EQRN has changed to 'Approval' on 05/21/2024. Application Category: BLA, Application Number: 761165, Application Classification:

    5/22/24 9:41:01 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for LOQTORZI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug LOQTORZI (SUPPL-1) with active ingredient TORIPALIMAB-TPZI has changed to 'Approval' on 04/22/2024. Application Category: BLA, Application Number: 761240, Application Classification:

    4/23/24 4:41:07 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for UDENYCA issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug UDENYCA (SUPPL-15) with active ingredient PEGFILGRASTIM-CBQV has changed to 'Approval' on 12/22/2023. Application Category: BLA, Application Number: 761039, Application Classification:

    12/27/23 4:38:39 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADBE
    $ADRT
    $APPH
    $ATIP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Matlin David J bought $216,664 worth of shares (33,333 units at $6.50), increasing direct ownership by 7% to 477,824 units (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    1/13/26 2:48:54 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Leong Yew Poh decreased direct ownership by 6% to 160,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    12/29/25 6:26:12 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    Director Leong Yew Poh decreased direct ownership by 6% to 170,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    12/8/25 7:08:12 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $ADRT
    $APPH
    $ATIP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    OpGen, Inc. (OTC: OPGN) Announces Name Change to CapForce Inc.

    CLARKSBURG, Md., Feb. 27, 2026 (GLOBE NEWSWIRE) -- OpGen, Inc. (OTC:OPGN) today announced that it is changing its name to CapForce Inc., effective today. OpGen changed its name to CapForce Inc. in order to reflect the repositioning of the Company's business to the digital investment banking and financial technology sectors. The name "CapForce" represents the "Force of Capital," symbolizing the Company's conviction as a next-generation category-defining fintech-powered investment bank that harnesses the intrinsic force of capital, through capital markets as the empowerment medium, to empower global mid-sized high growth companies to grow beyond the small-cap universe and punch above their w

    2/27/26 5:30:32 PM ET
    $OPGN
    Medical Specialities
    Health Care

    Healthcare Triangle Subsidiary QuantumNexis Inc. Launches its Dubai, UAE Operations to accelerate Digital Health Transformation across the GCC Countries

    The Dubai Operation strengthens Healthcare Triangle's mission to accelerate TeleHelath, Digital Therapeutics and population-scale care delivery across GCC.PLEASANTON, Calif., Feb. 27, 2026 /CNW/ -- Healthcare Triangle, Inc. (NASDAQ:HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industries, today announced that its subsidiary QuantumNexis Inc. has launched its Dubai, UAE operations in Meydan Free Zone to deliver clinically validated digital mental health solutions and AI powered Hospital Information System to the GCC markets. "This marks a major strategic expans

    2/27/26 7:18:00 AM ET
    $HCTI
    EDP Services
    Technology

    Healthcare Triangle Announces Approximately $3.959 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

    PLEASANTON, Calif., Feb. 26, 2026 /CNW/ -- Healthcare Triangle, Inc. (NASDAQ:HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced today that it has entered into definitive agreements for the purchase and sale of 681,553 shares of common stock (or prefunded warrants in lieu thereof), par value $0.00001 per share, at a purchase price of $5.81 per share in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about February 27, 2026, subject to the satisfaction of customary closing conditions. D. Boral Capital, LLC is acting as sole placement agent fo

    2/26/26 3:26:00 PM ET
    $HCTI
    EDP Services
    Technology

    $ADBE
    $ADRT
    $APPH
    $ATIP
    SEC Filings

    View All

    OpGen Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CapForce Inc. (0001293818) (Filer)

    2/27/26 5:29:02 PM ET
    $OPGN
    Medical Specialities
    Health Care

    Healthcare Triangle Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Healthcare Triangle, Inc. (0001839285) (Filer)

    2/27/26 5:00:18 PM ET
    $HCTI
    EDP Services
    Technology

    SEC Form 144 filed by Olema Pharmaceuticals Inc.

    144 - Olema Pharmaceuticals, Inc. (0001750284) (Subject)

    2/27/26 4:38:52 PM ET
    $OLMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $ADRT
    $APPH
    $ATIP
    Leadership Updates

    Live Leadership Updates

    View All

    Cohen & Company Announces Appointment of Pawel Skonieczka as Managing Director to Lead Coverage of Space Technology, Aerospace, & Communications Infrastructure in Capital Markets Segment

    NEW YORK, Feb. 26, 2026 /PRNewswire/ -- After nearly doubling deal flow and closing $43 billion in transactions in 2025, Cohen & Company Capital Markets ("CCM"), a division of Cohen & Company Securities, LLC, an indirect, controlled subsidiary of Cohen & Company Inc. (NYSE:COHN), announced the appointment of Pawel Skonieczka as a Managing Director to lead the expansion of the firm's advisory capabilities across Space Technology, Aerospace, and Communications Infrastructure. Mr. Skonieczka brings nearly two decades of experience advising public and private companies, financial sp

    2/26/26 10:43:00 AM ET
    $COHN
    Investment Bankers/Brokers/Service
    Finance

    Cohen & Company Announces Appointment of Senior Leadership to Expand Energy and Energy Transition Capabilities

    Firm Launches Houston Office Strategic Hire Anchors Firm's Expansion Across Energy, Power, and Infrastructure PHILADELPHIA and NEW YORK, Jan. 12, 2026 /PRNewswire/ -- After nearly doubling deal flow and closing $44 billion in transactions in 2025, Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, an indirect, controlled subsidiary of Cohen & Company Inc. (NYSE:COHN), today announced the appointment of senior leadership to its Energy and Energy Transition team, along with the opening of its Houston office to serve as the firm's hub for energy and energy transition advisory services.

    1/12/26 8:00:00 AM ET
    $COHN
    Investment Bankers/Brokers/Service
    Finance

    SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer

    ALISO VIEJO, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a late-stage biopharmaceutical company, today announced the appointment of Jean-Frédéric Viret, Ph.D., as the company's Chief Financial Officer (CFO). Dr. Viret brings over two decades of corporate finance experience in the life sciences industry, leading companies from early-stage clinical development through post-commercialization. At SpyGlass, he will lead the finance and accounting functions as the company advances the Bimatoprost Drug Pad-IOL System (BIM-IOL System) toward late-stage development and potential commercialization. "We are excited to welcome Jean to SpyGlass Pharma as we continue to advance our clin

    1/6/26 8:00:00 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADBE
    $ADRT
    $APPH
    $ATIP
    Financials

    Live finance-specific insights

    View All

    AEye to Report 2025 Fourth Quarter and Full Year Results on Monday, March 16 and Host Conference Call and Webcast

    AEye, Inc. (NASDAQ:LIDR), a global leader in software-defined, high-performance lidar solutions, today announced that it will release its 2025 fourth quarter and full year financial results, after market close on Monday, March 16, 2026. A conference call and webcast will be held on the same day, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). During the call, AEye CEO Matt Fisch and CFO Conor Tierney will review the company's financial results and provide a business update, followed by a question-and-answer session. Supplemental financial information will be available on the company's website prior to the conference call. The live webcast of the call with an accompanying slide prese

    2/23/26 11:00:00 AM ET
    $LIDR
    Auto Parts:O.E.M.
    Consumer Discretionary

    Community Health Systems, Inc. Announces Fourth Quarter and Year Ended December 31, 2025 Results

    Community Health Systems, Inc. (NYSE:CYH) (the "Company") today announced financial and operating results for the three months and year ended December 31, 2025. The following highlights the financial and operating results for the three months ended December 31, 2025. Net operating revenues totaled $3.106 billion. Net income attributable to Community Health Systems, Inc. stockholders was $110 million, or $0.81 per share (diluted), compared to net loss of $(70) million, or $(0.53) per share (diluted), for the same period in 2024. Excluding the adjusting items as presented in the table in footnote (e) on page 15, net income attributable to Community Health Systems, Inc. stockholders wa

    2/18/26 4:15:00 PM ET
    $CYH
    Hospital/Nursing Management
    Health Care

    Virgin Galactic Announces Date of Fourth Quarter and Full Year 2025 Financial Results and Conference Call

    Virgin Galactic Holdings, Inc. (NYSE:SPCE) ("Virgin Galactic" or the "Company") today announced that it will report its financial results for the fourth quarter and full year 2025 following the close of the U.S. markets on Monday, March 30, 2026. This date aligns with Securities and Exchange Commission rules requiring the Company, as a non-accelerated filer, to submit its annual report on Form 10-K within 90 days after the end of the fiscal year. Virgin Galactic will host a conference call to discuss the results that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). A live webcast and replay of the conference call will be available on the Company's Investor Relations website at inve

    2/17/26 4:06:00 PM ET
    $SPCE
    Transportation Services
    Consumer Discretionary

    $ADBE
    $ADRT
    $APPH
    $ATIP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by ATI Physical Therapy Inc.

    SC 13D/A - ATI Physical Therapy, Inc. (0001815849) (Subject)

    12/17/24 5:51:04 PM ET
    $ATIP
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by Olema Pharmaceuticals Inc.

    SC 13G - Olema Pharmaceuticals, Inc. (0001750284) (Subject)

    12/11/24 4:30:15 PM ET
    $OLMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by VCI Global Limited

    SC 13G - VCI Global Ltd (0001930510) (Subject)

    12/6/24 6:01:22 AM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary